ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Bristol Myers Squibb

Bristol Myers Squibb (BRM)

55.56
-0.47
( -0.84% )
Updated: 05:38:42
Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
55.56
Bid
55.56
Ask
55.88
Volume
185
55.56 Day's Range 56.29
36.315 52 Week Range 58.32
Market Cap
Previous Close
56.03
Open
56.29
Last Trade
60
@
55.56
Last Trade Time
04:54:48
Financial Volume
-
VWAP
-
Average Volume (3m)
7,988
Shares Outstanding
2,028,176,674
Dividend Yield
4.54%
PE Ratio
14.85
Earnings Per Share (EPS)
3.96
Revenue
45.01B
Net Profit
8.03B

About Bristol Myers Squibb

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Bristol Myers Squibb is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker BRM. The last closing price for Bristol Myers Squibb was 56.03 €. Over the last year, Bristol Myers Squibb shares have traded in a share price range of 36.315 € to 58.32 €.

Bristol Myers Squibb currently has 2,028,176,674 shares outstanding. The market capitalization of Bristol Myers Squibb is 113.64 € billion. Bristol Myers Squibb has a price to earnings ratio (PE ratio) of 14.85.

BRM Latest News

TOP NEWS: Bristol-Myers beats on revenue but swings to quarterly loss

Bristol-Myers Squibb Co on Thursday reported a swing to a first-quarter loss on charges related to its acquisition of ...

Bristol-Myers inks USD380 million supply agreement with Cellares

Bristol-Myers Squibb on Monday said it has signed an agreement to expedite the manufacturing of its CAR-T cell therap ...

IN BRIEF: BMS adds to neuroscience portfolio with Karuna acquisition

ibb Co - New York-based pharmaceutical company - Completes acquisition of Karuna Therapeutics Inc, a Massachusetts-bas ...

TOP NEWS: Bristol-Myers quarterly revenue up as new products shine

Bristol-Myers Squibb Co on Friday reported stronger fourth-quarter revenue, with sales from new drug launches increas ...

Bristol-Myers gets EMA validation for lung-cancer drug, repotrectinib

Bristol-Myers Squibb Co on Tuesday announced that the European Medicines Agency had validated an application for a lu ...

TOP NEWS: Bristol-Myers makes second holiday acquisition with RayzeBio

Bristol-Myers Squibb Co on Tuesday announced its second large acquisition in four days, saying it has agreed to buy N ...

TOP NEWS: Bristol-Myers swoops for schizophrenia drugmaker Karuna

Bristol-Myers Squibb Co on Friday agreed to buy biopharmaceutical company Karuna Therapeutics Inc for USD14.0 billion ...

Leading pharmaceutical firms highlight positive trial data on lymphoma

A number of leading pharmaceutical companies on Monday reported positive trial results on the treatment of lymphoma, ...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.220.39754246476355.3457.3954.71630455.8869078DE
47.34515.233848387448.21558.3248.0451072653.6000989DE
1210.09522.203893104645.46558.3243.01798849.73866701DE
2617.3445.368916797538.2258.3236.3151031243.66290898DE
5210.0622.109890109945.558.3236.3151084144.17879548DE
1564.889.6290449881650.6880.536.315492148.40611698DE
2604.117.9883381924251.4580.536.315443050.06819808DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NL8Genesis Ai Corp
0.018 €
(50.00%)
33k
BDDConico Ltd
0.0008 €
(33.33%)
80k
AXIAtos SE
0.7866 €
(32.20%)
1.82M
JNXTherma Bright Inc
0.0195 €
(25.81%)
30k
K8DWellfield Technologies Inc
0.025 €
(23.76%)
10k
L7C2Windfall Geotek Inc
0.0025 €
(-54.55%)
3.09k
TE9Teco 2030 ASA
0.0156 €
(-30.97%)
34.07k
EUSKore Mining Ltd
0.0165 €
(-26.67%)
900
GMEGeratherm Medic
3.86 €
(-26.48%)
29.59k
SL5Recharge Resources Ltd
0.023 €
(-25.81%)
17.75k
AXIAtos SE
0.7866 €
(32.20%)
1.82M
D7GNel ASA
0.2621 €
(-2.78%)
1.26M
9CHGalan Lithium Limited
0.0808 €
(-2.06%)
1.01M
24YBrainchip Holdings Ltd
0.1698 €
(11.64%)
621.48k
3CPXiaomi Corporation
3.431 €
(4.05%)
512.18k

Discussion

View Full Feed
Bull_Dolphin Bull_Dolphin 2 minutes ago
Hope that you never have to deal with this despicable agency:

https://x.com/matt_vanswol/status/1861467748192207228
sin vester sin vester 3 minutes ago
This board is trash😩
HIRU
Investor2014 Investor2014 5 minutes ago
Although not verified, I am assuming that a teapot is orbiting Mars.
AVXL
Bonous Bonous 5 minutes ago
BS!
NSAV
Seminole Red Seminole Red 5 minutes ago
best way to not hurt yourself is Not Move.....
sctts sctts 6 minutes ago
$$$ Today is the Day $$$$

$$$$ $FRX $$$$
FRX
tradernewstip tradernewstip 7 minutes ago
$ILLR is expanding its ecosystem to drive unique engagement across music, sports, and digital content. Triller Group’s integrated approach is designed to maximize value for investors by meeting the demands of today’s media landscape. #TrillerGroup #InvestorRelations #DigitalGrowth
https://tr
ILLR
Bull_Dolphin Bull_Dolphin 10 minutes ago
Finally:

https://revolver.news/2024/11/congress-just-put-ashli-babbit-killer-on-notice/

Well, it seems that Byrd is back in the crosshairs, and this time, he won’t have the Biden regime’s DOJ to protect him.

Investigative reporter Paul Sperry shared an up
Edward Edward 10 minutes ago
Absolutly amazing some are still thinking VXIT is a viable company.

Doesn't surprise me though, sub penny investors never ever sell even when it is clear the company is a Scam or will never survive.

In VXIT'S case, The CEO has criminal charges against him, no sales, ins
VXIT
sab63090 sab63090 11 minutes ago
Hopefully the company will consider using a good Investment Banking Team with some major players (MS, GS, JPM) to come up with some ways to do what is necessary; and that Missling even said was required!... I think he said that he can't do this alone.

They might find things like a siz
JPM
wagner wagner 11 minutes ago
I agree looking at the chart,

But this it say he is a criminal?

NB
SkeBallLarry SkeBallLarry 12 minutes ago
" I b'lieve I've got it tamed, @least for the time being " ...
mtsr mtsr 12 minutes ago
To me, this is the worst week for Stocks only because of the holiday most people buying or trading stocks usually or not this week
QBTS
diggitydoodle diggitydoodle 16 minutes ago
Let's see what happens here today. Aside from the last, nearly three years of daily nothing.
GLTA!
RNVA!!$$???????????????????????
RNVA
Bull_Dolphin Bull_Dolphin 16 minutes ago
Good morning Larry. Got that frisky computer under control again?
payupdeadbeat payupdeadbeat 18 minutes ago
Sadly, your constant optimism is old & faded. The sleeping duo is not participating. Maybe La la la Linda is in the Harvard cafeteria. 
DBMM
sab63090 sab63090 19 minutes ago
Hoskuld

I wasn't sure, but that 20 day posting I read about is probably the 2-3 week timeline to acceptance....I got up a while ago and just started catching up on things for today....let's hope we have a much better outcome than RETT was; I was so focused on that!

My
AVXL
Tadaaa Tadaaa 19 minutes ago
We are at the Golden Cross
HBARUSD
Just the facts maam Just the facts maam 21 minutes ago
Roddy, it also doesn't make sense to sell before announcing the drug approvals.

If North's suggestion is correct we may not get an announcement until the last NDA is approved in Q1, if all goes well.
ANIP
timberwolf7 timberwolf7 21 minutes ago
Got ATNM on my list of 'ones to monitor' cause its not going anywhere for a while.

What a frigging screw job both the company and shareholders just had to deal with.

If nothing else, the fda could have admitted ATNMs development HELPED people
who were dealing wit
ATNM
jeunke22 jeunke22 22 minutes ago
Institutional ownership up by 500k and Shorts down by 180k as of yesterday.
Despite relative weaker position in the Nasdaq index ( LWLG share price down, Nasdaq up) institutions increased their positions from 33.7 mio per 9/30 to 40.3 mio as of yesterday. That’s close to 7 mio shares in 6
LWLG
SkeBallLarry SkeBallLarry 23 minutes ago
" Grreat choice indeed, Bull ~ Good morning " .. !!